551 related articles for article (PubMed ID: 28494206)
1. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy.
Blank S; Etzold S; Darsow U; Schiener M; Eberlein B; Russkamp D; Wolf S; Graessel A; Biedermann T; Ollert M; Schmidt-Weber CB
Hum Vaccin Immunother; 2017 Oct; 13(10):2482-2489. PubMed ID: 28494206
[TBL] [Abstract][Full Text] [Related]
2. Component resolution reveals additional major allergens in patients with honeybee venom allergy.
Köhler J; Blank S; Müller S; Bantleon F; Frick M; Huss-Marp J; Lidholm J; Spillner E; Jakob T
J Allergy Clin Immunol; 2014 May; 133(5):1383-9, 1389.e1-6. PubMed ID: 24440283
[TBL] [Abstract][Full Text] [Related]
3. Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts.
Blank S; Seismann H; Michel Y; McIntyre M; Cifuentes L; Braren I; Grunwald T; Darsow U; Ring J; Bredehorst R; Ollert M; Spillner E
Allergy; 2011 Oct; 66(10):1322-9. PubMed ID: 21658068
[TBL] [Abstract][Full Text] [Related]
4. The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy.
Jakob T; Rauber MM; Perez-Riverol A; Spillner E; Blank S
Curr Allergy Asthma Rep; 2020 Jun; 20(9):48. PubMed ID: 32548726
[TBL] [Abstract][Full Text] [Related]
5. The major royal jelly proteins 8 and 9 (Api m 11) are glycosylated components of Apis mellifera venom with allergenic potential beyond carbohydrate-based reactivity.
Blank S; Bantleon FI; McIntyre M; Ollert M; Spillner E
Clin Exp Allergy; 2012 Jun; 42(6):976-85. PubMed ID: 22909169
[TBL] [Abstract][Full Text] [Related]
6. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
Frick M; Fischer J; Helbling A; Ruëff F; Wieczorek D; Ollert M; Pfützner W; Müller S; Huss-Marp J; Dorn B; Biedermann T; Lidholm J; Ruecker G; Bantleon F; Miehe M; Spillner E; Jakob T
J Allergy Clin Immunol; 2016 Dec; 138(6):1663-1671.e9. PubMed ID: 27372568
[TBL] [Abstract][Full Text] [Related]
7. The putative serine protease inhibitor Api m 6 from Apis mellifera venom: recombinant and structural evaluation.
Michel Y; McIntyre M; Ginglinger H; Ollert M; Cifuentes L; Blank S; Spillner E
J Investig Allergol Clin Immunol; 2012; 22(7):476-84. PubMed ID: 23397669
[TBL] [Abstract][Full Text] [Related]
8. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
Ruiz B; Serrano P; Moreno C
J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
[TBL] [Abstract][Full Text] [Related]
9. Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
Blank S; Seismann H; Bockisch B; Braren I; Cifuentes L; McIntyre M; Rühl D; Ring J; Bredehorst R; Ollert MW; Grunwald T; Spillner E
J Immunol; 2010 May; 184(9):5403-13. PubMed ID: 20348419
[TBL] [Abstract][Full Text] [Related]
10. IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology.
Van Vaerenbergh M; De Smet L; Rafei-Shamsabadi D; Blank S; Spillner E; Ebo DG; Devreese B; Jakob T; de Graaf DC
Mol Immunol; 2015 Feb; 63(2):449-55. PubMed ID: 25451974
[TBL] [Abstract][Full Text] [Related]
11. Vitellogenins are new high molecular weight components and allergens (Api m 12 and Ves v 6) of Apis mellifera and Vespula vulgaris venom.
Blank S; Seismann H; McIntyre M; Ollert M; Wolf S; Bantleon FI; Spillner E
PLoS One; 2013; 8(4):e62009. PubMed ID: 23626765
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3).
Grunwald T; Bockisch B; Spillner E; Ring J; Bredehorst R; Ollert MW
J Allergy Clin Immunol; 2006 Apr; 117(4):848-54. PubMed ID: 16630944
[TBL] [Abstract][Full Text] [Related]
13. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy.
Mittermann I; Zidarn M; Silar M; Markovic-Housley Z; Aberer W; Korosec P; Kosnik M; Valenta R
J Allergy Clin Immunol; 2010 Jun; 125(6):1300-1307.e3. PubMed ID: 20466415
[TBL] [Abstract][Full Text] [Related]
14. rApi m 3 and rApi m 10 improve detection of honey bee sensitization in Hymenoptera venom-allergic patients with double sensitization to honey bee and yellow jacket venom.
Frick M; Müller S; Bantleon F; Huss-Marp J; Lidholm J; Spillner E; Jakob T
Allergy; 2015 Dec; 70(12):1665-8. PubMed ID: 26259841
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2 (Api m 1) produced in insect cells.
Blank S; Michel Y; Seismann H; Plum M; Greunke K; Grunwald T; Bredehorst R; Ollert M; Braren I; Spillner E
Protein Pept Lett; 2011 Apr; 18(4):415-22. PubMed ID: 21171948
[TBL] [Abstract][Full Text] [Related]
16. Component Resolved Diagnosis in Hymenoptera Anaphylaxis.
Tomsitz D; Brockow K
Curr Allergy Asthma Rep; 2017 Jun; 17(6):38. PubMed ID: 28501976
[TBL] [Abstract][Full Text] [Related]
17. Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.
Schiener M; Graessel A; Ollert M; Schmidt-Weber CB; Blank S
Hum Vaccin Immunother; 2017 Oct; 13(10):2467-2481. PubMed ID: 28604163
[TBL] [Abstract][Full Text] [Related]
18. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
Müller UR; Johansen N; Petersen AB; Fromberg-Nielsen J; Haeberli G
Allergy; 2009 Apr; 64(4):543-8. PubMed ID: 19120073
[TBL] [Abstract][Full Text] [Related]
19. In situ imaging of honeybee (Apis mellifera) venom components from aqueous and aluminum hydroxide-adsorbed venom immunotherapy preparations.
Seppälä U; Francese S; Turillazzi S; Moneti G; Clench M; Barber D
J Allergy Clin Immunol; 2012 May; 129(5):1314-1320.e3. PubMed ID: 22104605
[TBL] [Abstract][Full Text] [Related]
20. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
